Last reviewed · How we verify

NCT05356650

Mulligan's Mobilization and Proprioceptive Neuromuscular Facilitation Technique in Sacroiliac Joint Dysfunction

Status unknown NA Last updated 2 May 2022
What this trial tests

NA trial testing Mulligan Mobilization in SACROILIAC JOINT DYSFUNCTION in 38 participants. Status unknown.

Timeline
15 April 2022
Primary endpoint
15 August 2022
15 September 2022

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment38
Start date15 April 2022
Primary completion15 August 2022
Estimated completion15 September 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 35, any sex, with SACROILIAC JOINT DYSFUNCTION. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will aim to compare the effects of mulligan mobilization and PNF on pain and disability with patients of SIJ dysfunction and will be helpful for clinical physiotherapist to choose more effective treatment protocol for patients as there are fewer researches on comparison of these techniques.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Mulligan Mobilization

Trials testing the same drug.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05356650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing